Shawn D. Spencer

1.7k total citations
39 papers, 1.3k citations indexed

About

Shawn D. Spencer is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shawn D. Spencer has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shawn D. Spencer's work include Prostate Cancer Treatment and Research (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Cancer Treatment and Pharmacology (4 papers). Shawn D. Spencer is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Cancer Treatment and Pharmacology (4 papers). Shawn D. Spencer collaborates with scholars based in United States, China and India. Shawn D. Spencer's co-authors include William D. Figg, Cody J. Peer, William D. Figg, Michael Pacanowski, Seth M. Steinberg, Giuseppe Giaccone, Arun Rajan, Éva Szabó, Ronan J. Kelly and Richard B. Horenstein and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Shawn D. Spencer

39 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shawn D. Spencer United States 20 536 384 188 179 161 39 1.3k
Sundeep Dugar United States 24 875 1.6× 330 0.9× 101 0.5× 180 1.0× 77 0.5× 70 1.9k
Shan Lin China 18 502 0.9× 162 0.4× 131 0.7× 155 0.9× 74 0.5× 90 1.2k
Rosario Vincenzo Iaffaioli Italy 24 424 0.8× 651 1.7× 100 0.5× 188 1.1× 111 0.7× 53 1.5k
Guanyu Wang China 23 685 1.3× 329 0.9× 135 0.7× 309 1.7× 98 0.6× 60 1.4k
Huijie Fan China 25 688 1.3× 297 0.8× 75 0.4× 273 1.5× 72 0.4× 70 1.4k
Carl Whatling Sweden 23 383 0.7× 174 0.5× 276 1.5× 247 1.4× 234 1.5× 44 1.5k
Ke Lin United Kingdom 27 927 1.7× 476 1.2× 114 0.6× 217 1.2× 141 0.9× 72 2.4k
Shan Deng China 26 1.1k 2.0× 488 1.3× 109 0.6× 514 2.9× 86 0.5× 71 2.0k
Fatima Mraiche Qatar 22 603 1.1× 164 0.4× 240 1.3× 115 0.6× 92 0.6× 60 1.3k
Hsiu‐Chuan Chou Taiwan 25 774 1.4× 243 0.6× 93 0.5× 185 1.0× 64 0.4× 85 1.6k

Countries citing papers authored by Shawn D. Spencer

Since Specialization
Citations

This map shows the geographic impact of Shawn D. Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shawn D. Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shawn D. Spencer more than expected).

Fields of papers citing papers by Shawn D. Spencer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shawn D. Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shawn D. Spencer. The network helps show where Shawn D. Spencer may publish in the future.

Co-authorship network of co-authors of Shawn D. Spencer

This figure shows the co-authorship network connecting the top 25 collaborators of Shawn D. Spencer. A scholar is included among the top collaborators of Shawn D. Spencer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shawn D. Spencer. Shawn D. Spencer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bagde, Arvind, et al.. (2024). 3D DLP-printed cannabinoid microneedles patch and its pharmacokinetic evaluation in rats. Journal of Pharmacy and Pharmacology. 76(6). 616–626. 6 indexed citations
2.
Bagde, Arvind, Satyanarayan Dev, Shawn D. Spencer, et al.. (2023). Biphasic burst and sustained transdermal delivery in vivo using an AI-optimized 3D-printed MN patch. International Journal of Pharmaceutics. 636. 122647–122647. 35 indexed citations
3.
North, Richard B., et al.. (2020). Cost-Effectiveness Model Shows Superiority of Wireless Spinal Cord Stimulation Implantation Without a Separate Trial. Neuromodulation Technology at the Neural Interface. 24(3). 596–603. 7 indexed citations
4.
Backman, Joshua, Jeffrey R. O’Connell, Keith Tanner, et al.. (2017). Genome-wide analysis of clopidogrel active metabolite levels identifies novel variants that influence antiplatelet response. Pharmacogenetics and Genomics. 27(4). 159–163. 19 indexed citations
5.
Andey, Terrick, Apurva R. Patel, Srujan Marepally, et al.. (2016). Formulation, Pharmacokinetic, and Efficacy Studies of Mannosylated Self-Emulsifying Solid Dispersions of Noscapine. PLoS ONE. 11(1). e0146804–e0146804. 13 indexed citations
6.
Marston, Louise, et al.. (2014). Non-invasive brain stimulation techniques for chronic pain. Brunel University Research Archive (BURA) (Brunel University London). 34 indexed citations
7.
Figg, William D., Cindy H. Chau, Ravi A. Madan, et al.. (2013). Phase II Study of Satraplatin and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Pharmacogenetic Assessment of Outcome and Toxicity. Clinical Genitourinary Cancer. 11(3). 229–237. 25 indexed citations
8.
Peer, Cody J., Jeffrey L. Brown, Jeffrey A. Roth, et al.. (2013). A novel uHPLC–MS/MS method for the quantitation of AZD7451 (AZ12607092) in human plasma. Journal of Chromatography B. 942-943. 107–112. 1 indexed citations
9.
Peer, Cody J., Mahadev Rao, Shawn D. Spencer, et al.. (2013). A rapid ultra HPLC–MS/MS method for the quantitation and pharmacokinetic analysis of 3-deazaneplanocin A in mice. Journal of Chromatography B. 927. 142–146. 8 indexed citations
10.
Rajan, Arun, Corey A. Carter, Ronan J. Kelly, et al.. (2012). A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors. Clinical Cancer Research. 18(8). 2344–2351. 125 indexed citations
11.
Spencer, Shawn D., Bernard L. Marini, & William D. Figg. (2012). Novel approaches in the pharmacotherapy of skeletal-related events in metastatic castrate-resistant prostate cancer.. PubMed. 32(7). 2391–8. 4 indexed citations
12.
Fang, Peng, Xiumei Wu, Shawn D. Spencer, et al.. (2012). Cytotoxic, cytoprotective and antioxidant effects of isolated phenolic compounds from fresh ginger. Fitoterapia. 83(3). 568–585. 104 indexed citations
13.
Gordon, Michael S., Lee S. Rosen, David S. Mendelson, et al.. (2012). A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors. Investigational New Drugs. 31(3). 714–723. 26 indexed citations
14.
Waldmann, Thomas A., Kevin C. Conlon, Donn M. Stewart, et al.. (2012). Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia. Blood. 121(3). 476–484. 56 indexed citations
15.
Patel, Apurva R., Shawn D. Spencer, Mahavir B. Chougule, Stephen Safe, & Mandip Singh. (2012). Pharmacokinetic evaluation and In Vitro–In Vivo Correlation (IVIVC) of novel methylene-substituted 3,3′ diindolylmethane (DIM). European Journal of Pharmaceutical Sciences. 46(1-2). 8–16. 20 indexed citations
16.
Kummar, Shivaani, Mark Raffeld, Lamin Juwara, et al.. (2011). Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1α in Advanced Solid Tumors. Clinical Cancer Research. 17(15). 5123–5131. 100 indexed citations
17.
Peer, Cody J., et al.. (2011). A sensitive and rapid ultra HPLC–MS/MS method for the simultaneous detection of clopidogrel and its derivatized active thiol metabolite in human plasma. Journal of Chromatography B. 880(1). 132–139. 44 indexed citations
18.
19.
Spencer, Shawn D. & Robert B. Raffa. (2004). Isothermal Titration Calorimetric Study of RNase-A Kinetics (cCMP → 3'-CMP) Involving End-Product Inhibition. Pharmaceutical Research. 21(9). 1642–1647. 11 indexed citations
20.
Spencer, Shawn D., et al.. (2002). Toward the Design of Ribonuclease (RNase) Inhibitors: Ion Effects on the Thermodynamics of Binding of 2′-CMP to RNase A. Journal of Pharmacology and Experimental Therapeutics. 301(3). 925–929. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sundeep Dugar Breakdown of academic impact, for papers by Shan Lin Breakdown of academic impact, for papers by Rosario Vincenzo Iaffaioli Breakdown of academic impact, for papers by Guanyu Wang Breakdown of academic impact, for papers by Huijie Fan Breakdown of academic impact, for papers by Carl Whatling Breakdown of academic impact, for papers by Ke Lin Breakdown of academic impact, for papers by Shan Deng Breakdown of academic impact, for papers by Fatima Mraiche Breakdown of academic impact, for papers by Hsiu‐Chuan Chou
Rankless by CCL
2026